Your Prostrate.com logo
Google
Web yourprostate.com.au

Prostate News Archive

20-Jul-2006

  • New diagnostic tool for prostate cancer (News-Medical-Net)

    According to the World Health Organization there are about 250,000 new cases of prostate cancer every year but, when caught in time, the disease has a cure rate of over 90%.


  • Impolite cancer fighter (Akron Beacon Journal)

    J. Bruce Hunsicker doesn't see any reason to be polite when it comes to prostate cancer.


  • Judge approves $200K settlement in lawsuit against Shortt (The State)

    A federal judge this morning approved a $200,000 settlement in a lawsuit by the widow of a man who died of prostate cancer while under Dr. James Shortt?s care.


  • Analysis: Prostate Drug for Alzheimer's? (RedNova)

    By ED SUSMAN Voyager Pharmaceutical Corp.'s investigational drug -- commonly used to treat prostate cancer -- received mixed results Wednesday from its phase 2 study in the treatment of men and women with mild-to-moderate Alzheimer's disease.


  • Biomira Stimuvax prostate cancer study results published (News-Medical-Net)

    Biomira Inc. has announced publication of study results showing that Stimuvax, formerly known as BLP25 Liposome Vaccine or L-BLP25, could slow rising Prostate Specific Antigen (PSA) levels in some post-surgical prostate cancer patients


  • A New Diagnostic Tool For Prostate Cancer And How A "bigger" Chromosome 8 Can Predict Poorer Outcomes In Prostate (Medical News Today)

    According to the World Health Organization there are about 250,000 new cases of prostate cancer every year but, when caught in time, the disease has a cure rate of over 90%. The problem is that the current methods of disease testing are still associated with too many misdiagnoses. [click link for full article]


  • Biomira Stimuvax(R) (L-BLP25) Prostate Cancer Study Results Published (CNW Group via Yahoo! Finance)

    Biomira Inc. , today announced publication of study results showing that Stimuvax, formerly known as BLP25 Liposome Vaccine or L-BLP25, could slow rising Prostate Specific Antigen levels in some post-surgical prostate cancer patients, potentially delaying the need for initiation of androgen deprivation therapy .


  • Watchful Waiting on Prostate Cancer (KABC-TV Los Angeles)

    The purpose of detecting prostate cancer is to catch it while it's easy to cure. But now some younger patients are chosing not to immediately get the traditional treatment for the disease. And they say it's a scary choice.


  • Back to Prostate News Archive